Cargando…
Cytotoxicity of Different Excipients on RPMI 2650 Human Nasal Epithelial Cells
The nasal route receives a great deal of attention as a non-invasive method for the systemic administration of drugs. For nasal delivery, specific formulations containing excipients are used. Because of the sensitive respiratory mucosa, not only the active ingredients, but also additives need to be...
Autores principales: | Horváth, Tamás, Bartos, Csilla, Bocsik, Alexandra, Kiss, Lóránd, Veszelka, Szilvia, Deli, Mária A., Újhelyi, Gabriella, Szabó-Révész, Piroska, Ambrus, Rita |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6273048/ https://www.ncbi.nlm.nih.gov/pubmed/27213303 http://dx.doi.org/10.3390/molecules21050658 |
Ejemplares similares
-
Applicability of RPMI 2650 and Calu-3 Cell Models for Evaluation of Nasal Formulations
por: Sibinovska, Nadica, et al.
Publicado: (2022) -
Comparison of Modern In Vitro Permeability Methods with the Aim of Investigation Nasal Dosage Forms
por: Bartos, Csilla, et al.
Publicado: (2021) -
Physico-Chemical and In Vitro Characterization of Chitosan-Based Microspheres Intended for Nasal Administration
por: Bartos, Csilla, et al.
Publicado: (2021) -
Expression of Estrogen Receptor-alpha in Nasal Polyps and the Effects of Dexamethasone on Estrogen Receptor-alpha Expression in RPMI 2650 Cells
por: Ban, Won Woo, et al.
Publicado: (2020) -
The Development of an In Vitro Horizontal Diffusion Cell to Monitor Nasal Powder Penetration Inline
por: Gieszinger, Péter, et al.
Publicado: (2021)